Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

NICE Expects FY23 Revenue of $2.359B-$2.379B Vs $2.36B Est, Adj EPS of $8.58-$8.78 Vs $8.52 Est, FY24 Cloud Revenue Growth of 18% YoY

By Benzinga Newsdesk
November 16, 6:37 AM
Full-Year 2023 Guidance: Raising Full-Year 2023 Guidance: The Company increased full-year 2023 Non-GAAP total revenues to an expected range of $2,359 million to $2,379 million,

NICE

Read More
1 minute read
  • Guidance
  • News

Maximus Sees FY24 EPS $5.05-$5.35 Vs $4.16 Est.; Revenue $5.05B-$5.20B Vs $5.18B Est.

By Benzinga Newsdesk
November 15, 5:18 PM
Fiscal Year 2024 Outlook

MAXN

Read More
2 minute read
  • Guidance
  • News

Maxeon Solar Technologies Sees Q4 Revenue $220M-$260M Vs $278.29M Est.; FY23 Revenue $1.114B-$1.154B Vs $1.2B Est.

By Benzinga Newsdesk
November 15, 5:15 PM
Fourth Quarter 2023 and Fiscal Year 2023 OutlookFor the fourth quarter of 2023, the Company anticipates the following results:(In millions, except shipments) OutlookShipments, in MW610 - 650Revenue(5)$220 -

MAXN

Read More
2 minute read
  • Guidance
  • News

MorphoSys AG Updates FY23 Monjuvi U.S. Net Product Sales From $80M-$95M To $85M-$95M

By Benzinga Newsdesk
November 15, 5:05 PM
Updated Full Year 2023 Financial Guidance:The updated financial guidance was issued on October 25, 2023. Updated 2023Financial GuidancePrevious 2023Financial Guidance*2023 Guidance InsightsMonjuvi U.S. net

MOR

Read More
2 minute read
  • Guidance
  • News

Stone Presents Plans For More Than Doubling Profitability Over The Next 4 Years, Hoping To Exceed An Adjusted Net Income Of R$4.3B; In 2027, Plans To Exceed R$600B In TPV And A Take Rate Above 2.70% In MSMB, Exceed R$14B In Client Deposits, And Achieve…

By Benzinga Newsdesk
November 15, 4:30 PM
The announcement was made during the Investor Day held in New York, for presenting the company's medium- and long-term plans

STNE

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?

By Vandana Singh
November 15, 3:30 PM
Heron Therapeutics Inc (NASDAQ: HRTX) reported Q3 sales of $31.43 million, missing the consensus of $32.75 million.

HRTX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Catalent’s Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta’s Gene Therapy

By Vandana Singh
November 15, 3:26 PM
Catalent Inc's (NYSE: CTLT) Q1 FY24 revenue of $982 million decreased 4% as reported, or 6%, in constant currency, beating the 

CTLT

Read More
1 minute read
  • Analyst Ratings
  • Earnings
  • Guidance
  • Markets
  • News
  • Price Target
  • Trading Ideas

These Analysts Revise Their Forecasts On Energizer Following Q4 Results

By Lisa Levin
November 15, 1:44 PM
Energizer Holdings, Inc. (NYSE: ENR) reported better-than-expected fourth-quarter results.

ENR

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Markets
  • News
  • Small Cap

Israeli Company ZIM Integrated Shipping Posts Huge Q3 Loss, Slashes FY23 Outlook Again

By Lekha Gupta
November 15, 1:32 PM
ZIM Integrated Shipping Services Ltd (NYSE: ZIM) reported a Q3 FY23 sales decline of 61% Y/Y to $1.27 billion, 

ZIM

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Jumia Technologies Narrows FY23 Adj. EBITDA Loss Outlook, Thanks To Cost Savings: Details

By Lekha Gupta
November 15, 12:58 PM
Jumia Technologies AG (NYSE: JMIA) reported a Q3 FY23 sales decline of 11.1% Y/Y to $44.9 million, missing the 

JMIA

Posts pagination

Previous 1 … 186 187 188 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service